Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Bai

Showing results (811-820 of 849) with videos related to

Pageof 85
Sort By:
Cellular & Molecular Immunology|April 13, 2026
MAIT cell plasticity generates CD4<sup>+</sup> MAIT cells that promote HCC progression via metabolic crosstalk with tumor cellsSicheng Fu, Maoyu Tang, Changfeng Zhao, et al.
The Journal of Experimental Medicine|August 3, 2021
ASC deglutathionylation is a checkpoint for NLRP3 inflammasome activationShuhang Li, Linlin Wang, Zhihao Xu, et al.
Cardiovascular Diabetology|May 23, 2024
Triglyceride-glucose index and health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studiesJia-Li Yin, Jing Yang, Xin-Jian Song, et al.
Annals of Family Medicine|November 25, 2024
Health Care Utilization After a Visit to a Within-Group Family Physician vs a Walk-In Clinic PhysicianChristine Salahub, Peter C Austin, Li Bai, et al.
Journal of Leukocyte Biology|July 21, 2023
HIVEP3 inhibits fate decision of CD8+ invariant NKT cells after positive selectionQielan Wu, Shiyu Bai, Miya Su, et al.
Preventive Medicine|May 8, 2023
Up-to-date on cancer screening among Ontario patients seen by walk-in clinic physicians: A retrospective cohort studyAisha Lofters, Christine Salahub, Peter C Austin, et al.
Science China. Life Sciences|April 23, 2026
Artemisinin derivative SM934 targets α-enolase to inhibit PEP-mediated TAK1 stabilization and inflammationJun Pan, Yuwei Zhang, Zhiwei Du, et al.
Cancer Communications (London, England)|May 26, 2019
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trialYuankai Shi, Jin Li, Jianming Xu, et al.
International Journal of Biological Macromolecules|October 17, 2024
A bispecific antibody targeting the Ig domains of Siglec-E displays enhanced antitumor effectsDan Zhao, Muziying Liu, Weihong Zeng, et al.
Parasitology Research|April 1, 2021
Dynamic transcriptome landscape of Paragonimus proliferus developmental stages in the rat lungsSheng-Hao Li, Yong-Rui Yang, Jun-Yi Li, et al.
Pageof 85

Showing results (811-820 of 849) with videos related to

Sort By:
Pageof 85
Cellular & Molecular Immunology|April 13, 2026
MAIT cell plasticity generates CD4<sup>+</sup> MAIT cells that promote HCC progression via metabolic crosstalk with tumor cellsSicheng Fu, Maoyu Tang, Changfeng Zhao, et al.
The Journal of Experimental Medicine|August 3, 2021
ASC deglutathionylation is a checkpoint for NLRP3 inflammasome activationShuhang Li, Linlin Wang, Zhihao Xu, et al.
Cardiovascular Diabetology|May 23, 2024
Triglyceride-glucose index and health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studiesJia-Li Yin, Jing Yang, Xin-Jian Song, et al.
Annals of Family Medicine|November 25, 2024
Health Care Utilization After a Visit to a Within-Group Family Physician vs a Walk-In Clinic PhysicianChristine Salahub, Peter C Austin, Li Bai, et al.
Journal of Leukocyte Biology|July 21, 2023
HIVEP3 inhibits fate decision of CD8+ invariant NKT cells after positive selectionQielan Wu, Shiyu Bai, Miya Su, et al.
Preventive Medicine|May 8, 2023
Up-to-date on cancer screening among Ontario patients seen by walk-in clinic physicians: A retrospective cohort studyAisha Lofters, Christine Salahub, Peter C Austin, et al.
Science China. Life Sciences|April 23, 2026
Artemisinin derivative SM934 targets α-enolase to inhibit PEP-mediated TAK1 stabilization and inflammationJun Pan, Yuwei Zhang, Zhiwei Du, et al.
Cancer Communications (London, England)|May 26, 2019
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trialYuankai Shi, Jin Li, Jianming Xu, et al.
International Journal of Biological Macromolecules|October 17, 2024
A bispecific antibody targeting the Ig domains of Siglec-E displays enhanced antitumor effectsDan Zhao, Muziying Liu, Weihong Zeng, et al.
Parasitology Research|April 1, 2021
Dynamic transcriptome landscape of Paragonimus proliferus developmental stages in the rat lungsSheng-Hao Li, Yong-Rui Yang, Jun-Yi Li, et al.
Pageof 85